4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 500mg

2-Chloro-6-(trichloromethyl)pyridine, 98.0%, 100g

Biphenylene, 95.0%, 1g

(S)-5-(Chloromethyl)oxazolidin-2-one, 95.0%, 100g

7-Oxa-1-azaspiro[4.4]nonane hydrochloride, 97.0%, 100mg

Ethyl 2-cyclohexylacetate, 95.0%, 100g

3-Bromo-1H-pyrazolo[4,3-b]pyridine-5-carboxylic acid, 98%, 1g

(3-(Cyanomethoxy)phenyl)boronic acid, 95.0%, 1g

(3-(Methylsulfonamidomethyl)phenyl)boronic acid, 95.0%, 250mg

5-Amino-2-methoxypyridine>97.0%(GC)(T)5g

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate, 95.0%, 25g

Ethyl 5-bromo-2-chlorobenzoate, 98.0%, 1g

3-aminobenzoic acid, >=98%, for synthesis, 250 g, plastic packaging.